People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Portola Pharmaceuticals Inc | — | Pharmaceuticals | Series C | $158.1M | $315.8M | 2011 |
William Lis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William Lis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Topper | 1 | 12 |
| Russell Hirsch | 1 | 10 |
| JEFF BIRD | 1 | 7 |
| Jean George | 1 | 6 |
| Nicholas Galakatos | 1 | 6 |
| Alan Frazier | 1 | 5 |
| Farah Champsi | 1 | 5 |
| Charles Homcy | 1 | 4 |
| Jean-Jacques Bienaime | 1 | 1 |
| Henry Ward Wolff | 1 | 1 |
| Mardi Dier | 1 | 1 |
| Hollings Ward Renton | 1 | 1 |
| Peggy Phillips | 1 | 1 |
| Pamela Green | 1 | 1 |
| David R. Phillips | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.